AVADEL PHARMACEUTICALS PLC Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q4 2011 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Avadel Pharmaceuticals Plc quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2011 to Q3 2022.
  • Avadel Pharmaceuticals Plc Deferred Tax Assets, Net of Valuation Allowance for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $0 -$29.8M -100% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $0 -$24.5M -100% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $28.6M +$7.79M +37.5% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $24.1M +$5.87M +32.2% Dec 31, 2021 10-Q 2022-11-09
Q3 2021 $29.8M +$14.3M +92.5% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $24.5M -$4.7M -16.1% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $20.8M -$17.1M -45.1% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $18.3M -$11.2M -38% Dec 31, 2020 10-Q 2021-11-08
Q3 2020 $15.5M -$6.16M -28.5% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $29.2M +$8.11M +38.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $37.9M +$14.6M +63.1% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $29.4M +$6.4M +27.8% Dec 31, 2019 10-Q 2020-11-09
Q3 2019 $21.6M +$13.5M +167% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $21.1M +$14.6M +226% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $23.2M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $23M +$19.2M +494% Dec 31, 2018 10-Q 2019-11-12
Q3 2018 $8.11M Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $6.46M Jun 30, 2018 10-Q 2018-08-07
Q4 2017 $3.88M -$6.47M -62.5% Dec 31, 2017 10-Q 2018-11-05
Q4 2016 $10.3M +$4.68M +82.8% Dec 31, 2016 10-K 2018-03-16
Q4 2015 $5.66M -$5.7M -50.2% Dec 31, 2015 10-K 2017-03-28
Q4 2014 $11.4M -$2.37M -17.3% Dec 31, 2014 10-K 2016-03-15
Q4 2013 $13.7M +$8.77M +177% Dec 31, 2013 20-F/A 2015-10-01
Q4 2012 $4.96M +$4.7M +1821% Dec 31, 2012 20-F/A 2015-10-01
Q4 2011 $258K Dec 31, 2011 20-F/A 2014-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.